Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

110
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
110
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

77
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
77
Survival Tree01:19

Survival Tree

48
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
48
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

147
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
147
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

142
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
142
Cancer Survival Analysis01:21

Cancer Survival Analysis

315
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
315

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reimagining radiological risk communication in Canada.

Annals of the ICRP·2026
Same author

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Nature communications·2026
Same author

A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples.

The Journal of infectious diseases·2025
Same author

Generalized nonparametric temporal modeling of recurrent events with application to a malaria vaccine trial.

Biometrics·2025
Same author

Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

A SARS-CoV-2 variant‑adjusted threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19.

Nature communications·2025
Same journal

Individualized dynamic latent factor model for multi-resolutional data with application to mobile health.

Biometrika·2026
Same journal

Functional principal component analysis forsparse censored data.

Biometrika·2026
Same journal

Finding distributions that differ, with false discovery rate control.

Biometrika·2026
Same journal

Sequential Gibbs posteriors with applications to principal component analysis.

Biometrika·2026
Same journal

Comparing causal parameters with many treatments and positivity violations.

Biometrika·2026
Same journal

Leveraging External Data for Testing Experimental Therapies with Biomarker Interactions in Randomized Clinical Trials.

Biometrika·2026
See all related articles

Related Experiment Video

Updated: May 21, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.6K

Assessing variable importance in survival analysis using machine learning.

C J Wolock1, P B Gilbert2, N Simon3

  • 1Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, 432 Guardian Drive, Philadelphia, Pennsylvania 19104, USA.

Biometrika
|March 19, 2025
PubMed
Summary
This summary is machine-generated.

Quantifying feature importance in predictive models is crucial for understanding factors influencing outcomes like HIV acquisition. This study introduces new methods for assessing variable importance in survival data, applicable to HIV vaccine trials.

Keywords:
CensoringDebiased machine learningFeature importanceTime-to-event outcome

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Related Experiment Videos

Last Updated: May 21, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.6K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Machine Learning

Background:

  • Assessing feature importance is vital for predictive modeling, particularly in clinical trials predicting outcomes like HIV acquisition.
  • Existing variable importance methods are often unsuitable for time-to-event data with right censoring, common in HIV vaccine research.
  • Understanding the contribution of specific predictors, such as behavioral factors, to overall predictiveness is a key research objective.

Purpose of the Study:

  • To develop and validate novel, algorithm-agnostic measures of variable importance for prediction tasks involving survival data.
  • To address the limitations of existing methods in handling right-censored time-to-event outcomes.
  • To provide tools for analyzing participant characteristics and informing strategies in HIV vaccine trials.

Main Methods:

  • Proposed a class of nonparametric, efficient estimation procedures for variable importance in survival analysis.
  • Incorporated flexible learning of nuisance parameters to ensure asymptotically valid inference.
  • Utilized a double-robust estimation approach for enhanced reliability.

Main Results:

  • Demonstrated the performance of the proposed variable importance measures through numerical simulations.
  • Applied the methods to analyze data from the HVTN 702 HIV vaccine trial.
  • The developed methods provide robust assessment of feature contributions in censored survival data.

Conclusions:

  • The proposed methods offer a robust and flexible approach to assessing variable importance in the context of survival data.
  • These tools can enhance the interpretation of predictive models in clinical trials, including those for HIV vaccines.
  • Findings can inform future HIV vaccine trial design and participant selection strategies.